Congenital And Structural Interventions (CSI)

The 2026 Congress on Congenital and Structural Heart Disease Interventions (CSI) will take place in Frankfurt, Germany, from June 3 to June 6, 2026. The CSI Congress is a significant global event in cardiovascular interventional therapy, focusing on the latest interventional techniques and innovations for congenital and structural heart diseases. Although information technology is not directly mentioned in the exhibition title, given the deep integration of modern medical technology with information technology, especially in diagnosis, imaging, surgical navigation, data management, and telemedicine, information technology plays an increasingly central role in such specialized medical conferences. The CSI Congress aims to bring together top global cardiologists, interventional physicians, researchers, medical device manufacturers, and relevant information technology service providers to discuss and showcase the latest advancements, cutting-edge technologies, and clinical applications in cardiovascular interventional therapy. The congress typically provides attendees with a comprehensive platform for learning, exchange, and collaboration through various formats such as plenary lectures, case discussions, live demonstrations, technical workshops, and product exhibitions. Its target audience includes cardiovascular internists, cardiothoracic surgeons, pediatric cardiologists, imaging specialists, anesthesiologists, nurses, as well as professionals from the medical device and information technology industries. The CSI Congress has a significant impact on promoting technological progress and optimizing clinical practice in the field of cardiovascular interventional therapy, making it an ideal venue for understanding industry trends, acquiring the latest knowledge, and expanding professional networks.

Interventional devices for congenital heart disease: occluders, stents, balloon catheters, guidewires, sheaths, vascular access products; Interventional devices for structural heart disease: transcatheter aortic valve replacement (TAVR) devices, transcatheter mitral valve repair/replacement devices, tricuspid valve interventional devices, left atrial appendage occluders, patent foramen ovale (PFO) occluders, atrial septal defect (ASD) occluders, ventricular septal defect (VSD) occluders; Cardiovascular imaging diagnostic equipment: echocardiography equipment, cardiovascular CT, cardiovascular MRI, angiography systems, 3D reconstruction software; Surgical navigation and positioning systems; Cardiovascular interventional surgical robots; Electrophysiology equipment and technology; Cardiovascular disease management information systems: electronic health record (EHR) systems, picture archiving and communication systems (PACS), telemedicine platforms, cardiovascular data analysis and artificial intelligence solutions; Wearable cardiovascular monitoring devices; Cardiovascular rehabilitation equipment and technology; Biomedical materials and implants; Extracorporeal circulation equipment; Anesthesia and life support equipment; Integrated operating room solutions; Disinfection and infection control products; Cardiovascular drugs and drug-device combination products; Research and education models; Professional publications and database services; Medical device regulatory consulting and certification services; Medical information security solutions.

No fee information available. Please contact us for a quote.